Planning Grant for CTSA at MUSC

MUSC 的 CTSA 规划拨款

• 批准号: 7216501
• 负责人: KATHLEEN T. BRADY
• 金额: $ 21.9万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-09-20 至 2008-09-19
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7216501
• 关键词: NIH Roadmap Initiative tag; biomedical facility; clinical research; education evaluation /planning; experimental designs; health science research potential; information dissemination; interdisciplinary collaboration; medical outreach /case finding; training

DESCRIPTION (provided by applicant): This proposal focuses on a planning process to develop an academic home for clinical and translational science as a discipline and transform the way in which clinical and translational researchers are trained and supported at the Medical University of South Carolina (MUSC). MUSC currently has a diverse portfolio of clinical and translational research activities, including an NIH-funded GCRC and interdisciplinary Roadmap T32 Program. The planning activities will bring together individuals with substantial clinical, basic science, administrative and community outreach expertise from MUSC and other institutions in the state. The highest level of MUSC leadership will be integrally involved as well as political and business leaders from throughout the state. The planning activities will be co-directed by two physician-scientists who are well-established translational researchers and exemplary mentors. Oversight and integration will be provided by an Institutional Planning Committee composed of researchers and administrative leaders with the experience, enthusiasm and authority to prioritize and implement the changes needed to transform the culture and infrastructure to achieve the overall objective. The planning period has 3 phases spanning 18 months (needs assessment, plan integration, and implementation). The university has committed institutional funds to support planning activities prior to the potential award date, and for supplemental support during the anticipated award period. The following approaches will be utilized-analysis of strategic strengths, weakness, opportunities, and threats (SWOT); work groups who will conduct a needs assessment and develop concrete recommendations in 12 focal areas; and expert consultation from a professional consulting firm in organization planning and change management as well as academic/scientific leaders in clinical and translational research from other organizations that are at amore advanced level of clinical and translational research development and implementation. The specific aims of this proposal are to: (1) Identify the optimal structure and infrastructure for the CTSA at MUSC; (2)Assess resources and needs that are critical to develop and sustain clinical and translational research as a discipline with a true academic home at MUSC; (3) Design new programs or services to address critical needs identified in the planning process, (4) Integrate existing resources to enhance the clinical and translational activities of MUSC and the institutions, agencies and clinical networks with which we collaborate locally, statewide, and nationally. A milestone of the planning process is submission of a competitive CTSA U54 proposal. Our plan includes assessments designed to facilitate and evaluate cultural and organizational change on an ongoing basis. The development and subsequent implementation of the strategic plan has the potential to transform the research enterprise of MUSC and the state.

描述（由申请人提供）：该提案侧重于规划过程，以开发临床和转化科学作为一门学科的学术家园，并改变南卡罗来纳医科大学（MUSC）培训和支持临床和转化研究人员的方式。 MUSC 目前拥有多样化的临床和转化研究活动组合，包括 NIH 资助的 GCRC 和跨学科路线图 T32 计划。规划活动将汇集来自 MUSC 和该州其他机构的具有丰富临床、基础科学、行政和社区外展专业知识的个人。 MUSC 的最高领导层以及全州的政治和商业领袖将全面参与其中。规划活动将由两位医学科学家共同指导，他们是知名的转化研究人员和模范导师。由具有经验、热情和权威的研究人员和行政领导组成的机构规划委员会将提供监督和整合，以优先考虑和实施文化和基础设施转型所需的变革，以实现总体目标。规划期分为 18 个月的 3 个阶段（需求评估、计划整合和实施）。该大学已投入机构资金来支持潜在授予日期之前的规划活动，并在预期授予期间提供补充支持。将采用以下方法——战略优势、劣势、机会和威胁（SWOT）分析；工作组将在 12 个重点领域进行需求评估并提出具体建议；来自组织规划和变革管理方面的专业咨询公司的专家咨询，以及来自其他在临床和转化研究开发和实施方面处于更先进水平的组织的临床和转化研究学术/科学领导者的咨询。该提案的具体目标是： (1) 确定 MUSC 的 CTSA 的最佳结构和基础设施； (2) 评估对于发展和维持临床和转化研究至关重要的资源和需求，作为一门在 MUSC 拥有真正学术根基的学科； (3) 设计新的计划或服务，以满足规划过程中确定的关键需求，(4) 整合现有资源，加强 MUSC 以及我们在本地、全州和全国范围内合作的机构、机构和临床网络的临床和转化活动。规划过程的一个里程碑是提交具有竞争力的 CTSA U54 提案。我们的计划包括旨在促进和评估持续的文化和组织变革的评估。该战略计划的制定和后续实施有可能改变 MUSC 和国家的研究企业。